{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-103024","form_type":"8-K","ticker":"HNGE","cik":"0001673743","company_name":"Hinge Health, Inc.","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.607474+00:00","generated_at":"2026-05-17T20:47:39.198547+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Hinge Health Q2 revenue $139.1M (+55% YoY); non-GAAP operating income $26.1M; guides FY revenue $548-552M","bullets":["Revenue grew 55% YoY to $139.1M; GAAP gross margin 70%, non-GAAP gross margin 83%.","GAAP loss from ops $580.7M (incl $591M stock-based comp); non-GAAP income from ops $26.1M vs loss $14.4M.","Free cash flow $32.6M (incl $14.2M IPO tax adjustment) vs $14.0M; cash $415.1M.","Clients up 32% to 2,359; LTM calculated billings $568.4M, +55% YoY.","Q3 rev guidance $141-143M (41% YoY growth); FY rev guidance $548-552M (41% YoY growth)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-103024","json":"https://secwatch.observer/filing/0000950170-25-103024.json","markdown":"https://secwatch.observer/filing/0000950170-25-103024.md","text":"https://secwatch.observer/filing/0000950170-25-103024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1673743/000095017025103024/0000950170-25-103024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1673743/000095017025103024/hnge-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:47:39.198547+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}